Infant sibling studies have been at the vanguard of autism spectrum disorders (ASD) research over the past decade, providing important new knowledge about the earliest emerging signs of ASD and expanding our understanding of the developmental course of this complex disorder. Studies focused on siblings of children with ASD also have unrealized potential for contributing to ASD etiologic research. Moving targeted time of enrollment back from infancy toward conception creates tremendous opportunities for optimally studying risk factors and risk biomarkers during the pre-, peri- and neonatal periods. By doing so, a traditional sibling study, which already incorporates close developmental follow-up of at-risk infants through the third year of life, is essentially reconfigured as an enriched-risk pregnancy cohort study. This review considers the enriched-risk pregnancy cohort approach of studying infant siblings in the context of current thinking on ASD etiologic mechanisms. It then discusses the key features of this approach and provides a description of the design and implementation strategy of one major ASD enriched-risk pregnancy cohort study: the Early Autism Risk Longitudinal Investigation (EARLI).
Three experiments were conducted at separate locations to determine the effects of a trace mineral injection (TMI), Multimin 90, on heifer performance and reproduction. In Exp. 1, [spring-born, Angus, n = 93, body weight (BW) = 428 ± 45.2 kg], Exp. 2 (spring-born, Angus × Simmental, n = 120, BW = 426 ± 54.0 kg), and Exp. 3 (fall-born, commercial Angus, n = 199, BW = 345 ± 39.7 kg) heifers were stratified by BW within experiment and assigned to 1 of 2 treatments: a control, saline injection, or TMI at a dose of 1 mL/68 kg BW. Free choice mineral, containing Cu, Mn, Se, and Zn formulated to meet or exceed NRC recommendations, was supplemented to heifers. Injections were given 33 d prior to breeding at the initiation of a 14-d controlled internal drug release (CIDR)-prostaglandin protocol. There was no difference (P ≥ 0.37) in BW during Exp. 1. Additionally, there was no difference (P ≥ 0.52) in body condition score (BCS) at initiation or at artificial insemination (AI) and final pregnancy confirmation in Exp. 1; however, a greater (P = 0.03) BCS was noted for control heifers at breeding. Pregnancy rates to timed AI and overall pregnancy rates were also similar (P ≥ 0.74) regardless of treatment. During Exp. 2, BCS and BW did not differ (P ≥ 0.44) across treatments. There was a tendency (P = 0.07) for TMI heifers to have an increased AI pregnancy rate (62 vs. 45%) compared with control heifers despite no difference (P = 0.51) in overall pregnancy rate. In Exp. 3, BW was not different (P ≥ 0.39) across all time points. Also, BCS did not differ (P ≥ 0.45) at initiation, AI, or final pregnancy conformation. Interestingly, there was a tendency (P = 0.10) for TMI heifers to have an increased BCS at the time of breeding compared with control heifers. However, there were no differences (P ≥ 0.50) in AI and overall pregnancy rates. In 1 of 3 experiments, an injectable trace mineral administered 33 d prior to the breeding season in conjunction with a 14-d CIDR protocol, tended to increased AI conception rates of heifers even when adequate trace mineral supplement was provided. The variable response observed across experiments may be caused by differences in breed, calving season, mineral sources, and management strategies.
The objectives of this study were to determine the effects of feeding dried corn distillers grains (DDGS) or modified wet corn distillers grains (MDGS) with or without CaO treatment to feedlot steers on 1) growth performance and carcass characteristics and 2) diet digestibility, pattern of intake, and meal distribution. In Exp. 1, steers (n = 139; average initial BW = 336 ± 75 kg) were used in a randomized complete block design. Treatments were arranged in a 2 × 2 factorial design, and pens were randomly allotted to 1 of the 4 dietary treatments (DM basis): 1) 50% DDGS untreated, 2) 48.8% DDGS treated with 1.2% CaO, 3) 50% MDGS untreated, or 4) 48.8% MDGS treated with 1.2% CaO. The remainder of the diet was corn husklage, dry rolled corn, and vitamin and mineral supplement. In Exp. 2, fistulated steers (n = 8; average initial BW = 540 ± 250 kg) were used in a replicated 4 × 4 Latin square design with the same dietary treatments as in Exp. 1. There was no interaction (P ≥ 0.14) between distillers grains plus solubles (DGS) and CaO inclusion for DMI, ADG, final BW, or USDA yield and quality grades. However, steers fed CaO-treated DGS had decreased (P < 0.01) DMI, regardless of DGS type. Because CaO treatment decreased DMI without affecting (P = 0.66) ADG, steers fed CaO-treated DGS had increased (P < 0.01) G:F compared to steers not fed CaO. The variation in DMI found in this experiment could be explained by differences in meal size and distribution. Steers fed CaO-treated DGS ate a similar (P = 0.36) number of meals but ate smaller (P < 0.01) meals. No effects (P ≥ 0.55) of CaO treatment or its interaction with DGS type were found for apparent total tract DM or NDF digestibility. However, steers fed MDGS had increased (P < 0.01) NDF digestibility compared to steers fed DDGS. In conclusion, CaO treatment of DGS improved feed efficiency when DGS-based diets were fed but did not improve digestibility.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.